Le Lézard
Classified in: Health
Subjects: NPT, CSR, PSF, STP

Dohmen Company Foundation Pledges $75 Million Investment to Eliminate Diet-Related Disease


Commitment Unveiled During White House Conference on Hunger, Nutrition and Health

MILWAUKEE, Sept. 28, 2022 /PRNewswire/ -- Dohmen Company Foundation Chairperson Cynthia LaConte announced today that the Foundation has pledged $75 million over seven years to advance its vision of life without diet-related disease. The commitment was spotlighted during the White House Conference on Hunger, Nutrition & Health on September 28. President Biden has committed to advancing a national strategy to end hunger, improve healthy eating and physical activity, and eliminate disparities surrounding them by 2030.

"We believe the solution to improve the health of our nation is surprisingly simple. It's food. The very thing that's making us sick can become our prescription to health," said LaConte. "Our unprecedented $75 million investment in comprehensive healthy food solutions and healthy eating education will strive to reduce escalating rates of diet related disease that are costing American lives."

Foundation President and CEO Rachel Roller, who will represent the Dohmen Company Foundation at the Conference, said the Foundation will invest $75 million over the next seven years to design and operationalize three initiatives that promote "food as medicine" and reduce the morbidity of diet-related disease. The Foundation will launch:

"The Foundation and White House commitments underscore the power of private and public partnerships to collectively accelerate health improvement. We applaud the Biden Administration for advancing a comprehensive strategy to address poor diet, the leading risk factor for death in the United States. The Dohmen Company Foundation is doing its part to empower consumers to make the right food choices through education, awareness, and accessibility to healthy food. Together we can build a healthier and more equitable future for our nation," said Roller.

About the Dohmen Company Foundation

With more than 165 years of healthcare experience, Dohmen has found a way to combine the rigor of business with the heart of philanthropy, becoming the first organization in the nation to transition from a family-owned S-Corporation to a foundation-owned philanthropic enterprise. Today, focused on building community health rather than shareholder wealth, the Dohmen Company Foundation invests in efforts to realize a vision of life without diet-related disease. Dohmen pursues its vision through both its social business (which contributes 100% of its profits to charity) and its charitable giving. For more information, visit dohmencompanyfoundation.org.

About the White House Conference on Hunger, Nutrition and Health

The focus of the White House Conference on Hunger, Nutrition, and Health on September 28, 2022, is to announce a national strategy to end hunger, reduce diet-related diseases by improving healthy eating and physical activity, and eliminate disparities surrounding them by 2030. In conjunction with the conference, a National Policy Strategy has been released in advance of the Conference that lays out steps the government will be taking and catalyzes the public and private sectors to address the intersections between food, hunger, nutrition, and health. Watch the Conference live ? and learn about the soon-to-be released National Strategy for ending hunger and reducing diet-related diseases and disparities and The Dohmen Company Foundation's role in this national movement.

Media Contact:
Carole Pfeil
262.623.4054  
[email protected]

SOURCE The Dohmen Company Foundation


These press releases may also interest you

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...



News published on and distributed by: